Applied Molecular Transport Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Applied Molecular Transport.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 28.5% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
Here's Why We're A Bit Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Situation
Mar 07
We're A Little Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate
Nov 13Applied Molecular Transport GAAP EPS of -$0.93
Aug 04Companies Like Applied Molecular Transport (NASDAQ:AMTI) Could Be Quite Risky
Jul 27Applied Molecular Transport up 4% after hours on ulcerative colitis candidate data
Jul 05Applied Molecular: Interesting Drug Delivery Approach For The GI Tract
May 03We're Keeping An Eye On Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Rate
Apr 28We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely
Jan 08We're Hopeful That Applied Molecular Transport (NASDAQ:AMTI) Will Use Its Cash Wisely
Aug 29Applied Molecular Transport (NASDAQ:AMTI) Is In A Good Position To Deliver On Growth Plans
Apr 05Have Insiders Been Buying Applied Molecular Transport Inc. (NASDAQ:AMTI) Shares This Year?
Feb 11Here's Why We're Not Too Worried About Applied Molecular Transport's (NASDAQ:AMTI) Cash Burn Situation
Dec 21Applied Molecular Transport reports Q3 results
Nov 12In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Applied Molecular Transport has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2023 | N/A | -75 | -60 | -60 | N/A |
| 6/30/2023 | N/A | -93 | -76 | -75 | N/A |
| 3/31/2023 | N/A | -112 | -85 | -82 | N/A |
| 12/31/2022 | N/A | -126 | -98 | -94 | N/A |
| 9/30/2022 | N/A | -134 | -107 | -102 | N/A |
| 6/30/2022 | N/A | -135 | -104 | -99 | N/A |
| 3/31/2022 | N/A | -122 | -96 | -93 | N/A |
| 12/31/2021 | N/A | -100 | -84 | -83 | N/A |
| 9/30/2021 | N/A | -89 | -79 | -77 | N/A |
| 6/30/2021 | N/A | -80 | -77 | -73 | N/A |
| 3/31/2021 | N/A | -72 | -70 | -66 | N/A |
| 12/31/2020 | N/A | -67 | -64 | -59 | N/A |
| 9/30/2020 | N/A | -55 | -57 | -51 | N/A |
| 6/30/2020 | N/A | -46 | -47 | -43 | N/A |
| 3/31/2020 | N/A | -38 | -37 | -34 | N/A |
| 12/31/2019 | N/A | -28 | -29 | -27 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if AMTI's forecast earnings growth is above the savings rate (2.2%).
Earnings vs Market: Insufficient data to determine if AMTI's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if AMTI's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if AMTI's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if AMTI's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AMTI's Return on Equity is forecast to be high in 3 years time